AC Immune SA (ACIU)
2.93
-0.10
(-3.30%)
USD |
NASDAQ |
Apr 29, 16:00
2.955
+0.02
(+0.85%)
After-Hours: 20:00
AC Immune Total Liabilities (Quarterly) : 138.05M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 85.94B |
| Novartis AG | 79.61B |
| EvoNext Holdings SA | -- |
| Kuros Biosciences Ltd. | -- |
| Basilea Pharmaceutica AG | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 194.70M |
| Shareholders Equity (Quarterly) | 56.65M |
| Debt to Equity Ratio | 0.1012 |
| Current Ratio | 1.021 |
| Net Debt Paydown Yield | -0.13% |